NeoGenomics (NASDAQ: NEO) reported Q1 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $63.4 million versus the consensus estimate of $61.21 million.

GUIDANCE:

NeoGenomics sees FY2018 EPS of $0.15-$0.20, versus the consensus of $0.17. NeoGenomics sees FY2018 revenue of $260-272 million, versus the consensus of $263.9 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.